Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35

1.

Long-term results after in-situ split (ISS) liver resection.

Lang SA, Loss M, Benseler V, Glockzin G, Schlitt HJ.

Langenbecks Arch Surg. 2015 Apr;400(3):361-9. doi: 10.1007/s00423-015-1285-z. Epub 2015 Feb 18.

PMID:
25854503
2.
3.

Challenges in the multidisciplinary management of stage IV colon and rectal cancer.

Piso P, Arnold D, Glockzin G.

Expert Rev Gastroenterol Hepatol. 2015 Mar;9(3):317-26. doi: 10.1586/17474124.2015.957273. Epub 2014 Sep 5.

PMID:
25192718
4.

American Society of Peritoneal Surface Malignancies opinion statement on defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer.

Esquivel J, Piso P, Verwaal V, Bachleitner-Hofmann T, Glehen O, Gonz√°lez-Moreno S, Deraco M, Pelz J, Alexander R, Glockzin G.

J Surg Oncol. 2014 Dec;110(7):777-8. doi: 10.1002/jso.23722. Epub 2014 Jul 8. No abstract available.

PMID:
25043759
5.

Autofluorescent imaging in patients with peritoneal carcinomatosis.

von Breitenbuch P, Jeiter T, Schreml S, Glockzin G, Agha A, Piso P, Schlitt HJ.

Surg Innov. 2014 Apr;21(2):187-93. doi: 10.1177/1553350613495114. Epub 2013 Jul 9.

PMID:
23843158
6.

A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial.

Glockzin G, Rochon J, Arnold D, Lang SA, Klebl F, Zeman F, Koller M, Schlitt HJ, Piso P.

BMC Cancer. 2013 Feb 7;13:67. doi: 10.1186/1471-2407-13-67.

7.

Current status and future directions in gastric cancer with peritoneal dissemination.

Glockzin G, Piso P.

Surg Oncol Clin N Am. 2012 Oct;21(4):625-33. doi: 10.1016/j.soc.2012.07.002. Epub 2012 Sep 4. Review.

PMID:
23021720
8.

Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature.

Stein A, Glockzin G, Wienke A, Arnold D, Edelmann T, Hildebrandt B, Hollerbach S, Illerhaus G, Königsrainer A, Richter M, Schlitt HJ, Schmoll HJ.

BMC Cancer. 2012 Aug 16;12:356. doi: 10.1186/1471-2407-12-356. Review.

9.
10.

Different approaches for complete mobilization of the splenic flexure during laparoscopic rectal cancer resection.

Benseler V, Hornung M, Iesalnieks I, von Breitenbuch P, Glockzin G, Schlitt HJ, Agha A.

Int J Colorectal Dis. 2012 Nov;27(11):1521-9. doi: 10.1007/s00384-012-1495-6. Epub 2012 May 25.

PMID:
22622601
11.

Completion thyroidectomy: effect of timing on clinical complications and oncologic outcome in patients with differentiated thyroid cancer.

Glockzin G, Hornung M, Kienle K, Thelen K, Boin M, Schreyer AG, Lighvani HR, Schlitt HJ, Agha A.

World J Surg. 2012 May;36(5):1168-73. doi: 10.1007/s00268-012-1484-5.

PMID:
22366982
12.

Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer.

Taeger J, Moser C, Hellerbrand C, Mycielska ME, Glockzin G, Schlitt HJ, Geissler EK, Stoeltzing O, Lang SA.

Mol Cancer Ther. 2011 Nov;10(11):2157-67. doi: 10.1158/1535-7163.MCT-11-0312. Epub 2011 Sep 1.

13.

Hepatobiliary procedures in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Glockzin G, Renner P, Popp FC, Dahlke MH, von Breitenbuch P, Schlitt HJ, Piso P.

Ann Surg Oncol. 2011 Apr;18(4):1052-9. doi: 10.1245/s10434-010-1415-3. Epub 2010 Nov 3.

PMID:
21046262
14.

Single-incision retroperitoneoscopic adrenalectomy and single-incision laparoscopic adrenalectomy.

Agha A, Hornung M, Iesalnieks I, Glockzin G, Schlitt HJ.

J Endourol. 2010 Nov;24(11):1765-70. doi: 10.1089/end.2010.0238. Epub 2010 Sep 19.

PMID:
20849304
15.

[Surgical therapy for adrenal tumours].

Agha A, Iesalnieks I, Glockzin G, Schlitt HJ.

Zentralbl Chir. 2010 Jun;135(3):233-9. doi: 10.1055/s-0030-1247356. Epub 2010 Jun 14. Review. German.

PMID:
20549586
16.

Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.

Piso P, Glockzin G, von Breitenbuch P, Popp FC, Dahlke MH, Schlitt HJ, Nissan A.

J Surg Oncol. 2009 Sep 15;100(4):317-20. doi: 10.1002/jso.21327. Review.

PMID:
19697438
17.

Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.

Glockzin G, Ghali N, Lang SA, Schlitt HJ, Piso P.

J Surg Oncol. 2009 Sep 15;100(4):306-10. doi: 10.1002/jso.21332. Review.

PMID:
19697436
18.

Patient selection for a curative approach to carcinomatosis.

Piso P, Glockzin G, von Breitenbuch P, Sulaiman T, Popp F, Dahlke M, Esquivel J, Schlitt HJ.

Cancer J. 2009 May-Jun;15(3):236-42. doi: 10.1097/PPO.0b013e3181a58f30. Review.

PMID:
19556910
19.

[The techniques of peritonectomy and hyperthermic intraperitoneal chemotherapy].

Lang SA, Glockzin G, Dahlke MH, Popp FC, Agha A, Schlitt HJ, Piso P.

Zentralbl Chir. 2009 Sep;134(5):443-9. doi: 10.1055/s-0028-1098704. Epub 2009 Jun 2. Review. German.

PMID:
19492282
20.

Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.

Piso P, Slowik P, Popp F, Dahlke MH, Glockzin G, Schlitt HJ.

Ann Surg Oncol. 2009 Aug;16(8):2188-94. doi: 10.1245/s10434-009-0478-5. Epub 2009 May 2.

PMID:
19408049
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk